查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1554580

2024-2032 年日本核子造影市場報告（按產品（設備、放射性同位素）、應用（SPECT 應用、PET 應用）和地區）

Japan Nuclear Imaging Market Report by Product (Equipment, Radioisotope), Application (SPECT Applications, PET Applications), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 120 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

預計 2024 年至 2032 年日本核子造影市場的成長率 (CAGR) 為 4.24%。該市場正在經歷顯著成長，主要由技術進步、老年人口成長和慢性病發病率增加所推動。政府推動早期診斷、採用混合成像技術、大力投資研發（R&D）以提高診斷精度和效率的舉措正在推動日本核成像市場的成長。

日本核子造影市場分析：

  • 主要市場促進因素：主要市場促進因素包括癌症和心血管疾病等慢性病盛行率的上升，這需要先進的診斷影像技術。與此一致的是，不斷成長的老年人口進一步推動了對先進成像技術的需求，因為與成年人相比，老年人更容易出現這種情況。在研發 (R&D) 大量投資的支援下，影像設備的技術進步進一步提高了診斷程序的準確性和效率。此外，政府促進早期疾病檢測和改善醫療基礎設施的措施和政策顯著促進了日本核子造影市場的成長。將核子醫學與其他影像方式結合的混合成像技術的日益普及也為市場創造了積極的前景。
  • 主要市場趨勢：主要市場趨勢包括擴大採用混合成像技術，例如 PET/CT 和 SPECT/CT，這些技術透過結合功能性影像和解剖成像來提高診斷準確性。先進放射性藥物的使用也發生了重大轉變，這些藥物可提供更好的成像品質和針對特定診斷。市場正在經歷人工智慧和機器學習整合的顯著成長，以改善影像分析和簡化工作流程。此外，對個人化醫療的關注正在推動客製化核成像解決方案的開發，進而推動日本核子成像市場的成長。隨著減少輻射暴露和提高成像系統效率的努力，環境永續性正在成為當今的優先事項。
  • 競爭格局：市場主要參與者正在大力投資研發（R&D）以引入創新影像技術。如今，公司也在建立策略夥伴關係和協作，以擴大其產品組合和市場覆蓋範圍。此外，他們還透過創建更有效率、低輻射的影像解決方案來強調環境的永續性，以滿足監管標準並滿足醫療保健需求。
  • 挑戰與機會：市場面臨各種挑戰，例如與先進成像技術和放射性藥物相關的高成本，這可能限制可及性和可負擔性。新顯影劑和設備的監管障礙和嚴格的核准流程也造成了重大障礙。然而，這些挑戰也創造了巨大的機會。慢性病發病率的上升和老年人口的增加正在推動對精確診斷工具的需求。人工智慧和機器學習等技術進步為提高成像精度和效率提供了前景。此外，政府促進早期診斷和個人化醫療的措施也提供了重要的市場成長途徑。產業參與者和醫療機構之間的合作正在進一步促進日本核子造影市場的成長和創新。

日本核子造影市場趨勢：

慢性病盛行率上升

日本癌症盛行率不斷上升，需要先進的診斷工具，這使得核子影像對於早期檢測、準確分期和監測治療反應非常重要。根據日本國家醫學圖書館發布的報告顯示，自1981年以來，癌症一直是日本的首要死因，佔總死亡人數的1/3。 2022 年，新增癌症病例為 1,019,000 例，癌症死亡人數為 380,400 例。同樣，作為主要健康問題的心血管疾病也可以從 SPECT 和 PET 掃描等核子造影方式中受益匪淺。這些技術有助於評估心肌灌注、檢測缺血和評估心臟功能，從而促進及時、精確的干涉。對核子造影的日益依賴增強了這些慢性疾病的管理，有助於改善健康結果並延長患者的生存期。

老年人口增加

日本人口老化顯著增加了對核成像服務的需求，因為老年人通常需要頻繁地進行與年齡相關的健康問題的診斷程序。根據BBC發表的一篇文章稱，全國資料顯示，日本1.25億人口中，29.1%的人年齡在65歲以上。在日本，到2040年，65歲以上人口預計將佔總人口的34.8%。 。此外，與年齡相關的退化性疾病（例如阿茲海默症）受益於核子造影的早期干預。不斷成長的老年人口推動了日本核成像市場的成長，確保老年人更好的醫療保健結果和生活品質。

政府投資增加

日本政府對醫療保健基礎設施的投資對於推動核子成像市場至關重要。這些投資包括為最先進的影像技術和設施提供資金，確保醫療保健提供者能夠獲得最新的診斷工具。例如，日本健康 2025 旨在改變全球醫療保健，並專注於醫療創新和技術。隨著矽谷日本創新園區等措施以及精準醫學和再生醫學的進步，該國的醫療保健產業正在不斷發展。 Japan Health 致力於將日本與世界聯繫起來，並將其醫療保健產業提升到全球標準。這些進步提高了診斷準確性和患者護理，推動了核成像的採用。此外，有利的監管政策透過簡化新成像技術和放射性藥物的核准流程來支持市場的成長。政府促進核子造影研究和開發的措施可促進創新並促進尖端技術和治療的引進，最終改善整體醫療保健系統和患者治療效果。

日本核子造影市場細分：

IMARC Group提供了每個細分市場的主要趨勢的分析，以及 2024-2032 年國家和地區層面的預測。我們的報告根據產品和應用對市場進行了分類。

按產品分類：

  • 裝置
  • 放射性同位素
    • SPECT放射性同位素
  • 锝-99m (TC-99m)
  • 鉈-201 (TI-201)
  • 鎵 (Ga-67)
  • 碘 (I-123)
  • 其他
    • PET放射性同位素
  • 氟18 (F-18)
  • 銣-82 (RB-82)
  • 其他

該報告根據產品提供了詳細的市場細分和分析。這包括設備和放射性同位素[（SPECT 放射性同位素（锝-99m (tc-99m)、鉈-201 (ti-201)、鎵(ga-67)、碘(i-123) 等）和PET 放射性同位素（氟） -18 (f-18)、銣-82 (rb-82) 等）]。

日本核子成像設備市場是該國先進醫療基礎設施的重要組成部分。關鍵設備包括單光子發射電腦斷層掃描 (SPECT) 和正子斷層掃描 (PET) 掃描儀，這對於診斷各種疾病（包括癌症、心血管疾病和神經系統疾病）至關重要。日本人口老化、慢性病盛行率上升以及影像技術的進步推動了對此類設備的需求。此外，人工智慧和機器學習在成像設備中的整合提高了診斷準確性和效率，進一步推動市場成長。對醫療基礎設施的持續投資和對早期疾病檢測意識的不斷提高極大地促進了日本核成像設備市場的擴張。

放射性同位素是日本核子造影市場的基礎，為 SPECT 和 PET 影像技術提供必要的追蹤劑。 SPECT 放射性同位素，例如 Technetium-99m (Tc-99m) 和鉈-201 (Tl-201)，由於其良好的特性和可用性而廣泛用於心臟、骨骼和腫瘤成像。 PET 放射性同位素，包括氟 18 (F-18) 和銣 82 (Rb-82)，可提供對於檢測癌症、神經系統疾病和心血管疾病至關重要的高解析度影像。這些疾病的日益普及推動了對 SPECT 和 PET 放射性同位素的需求。日本強大的醫療基礎設施，加上對先進核醫學研究的關注，支持這些放射性同位素的不斷成長的利用，確保精確的診斷和有效的疾病管理。

按應用分類：

  • 單光子發射斷層掃描應用
    • 骨科
    • 甲狀腺
    • 心臟病學
    • 其他
  • 聚酯應用
    • 腫瘤學
    • 心臟病學
    • 神經病學
    • 其他

報告還提供了基於應用程式的詳細市場細分和分析。這包括 SPECT 應用（骨科、甲狀腺、心臟病學等）和 PET 應用（腫瘤學、心臟病學、神經學等）。

在日本，SPECT 應用對於診斷和監測各種健康狀況至關重要。骨科受益於 SPECT 影像檢測骨異常和骨折。甲狀腺影像利用 SPECT 評估甲狀腺功能並檢測甲狀腺功能亢進或甲狀腺癌等疾病。心臟科應用使用 SPECT 來評估心肌灌注並診斷冠狀動脈疾病。其他應用包括癲癇和失智症的腦部影像。這些疾病的盛行率不斷上升，加上 SPECT 技術的進步，推動了日本醫療保健產業對 SPECT 應用的需求，確保精確診斷並改善患者治療結果。

PET 應用是日本核子造影市場不可或缺的一部分，為各個醫療領域提供高解析度影像。腫瘤學嚴重依賴 PET 來檢測和分期癌症、監測治療反應和復發。心臟病學應用使用 PET 來評估心肌灌注和活力，有助於心臟病的診斷和治療。神經病學受益於 PET 影像來診斷和評估阿茲海默症和癲癇等神經系統疾病。其他應用包括感染和發炎成像。日本癌症、心血管和神經系統疾病的發生率不斷上升，推動了對 PET 應用的需求，從而增強了早期檢測和有效的治療策略。

按地區分類：

  • 關東地區
  • 關西/近畿地區
  • 中部/中部地區
  • 九州·沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

該報告還對所有主要區域市場進行了全面分析，包括關東地區、關西/近畿地區、中部/中部地區、九州沖繩地區、東北地區、中國地區、北海道地區和四國地區。

包括東京在內的關東地區是日本核子成像的重要市場。作為人口最多、經濟最發達的地區，它擁有先進的醫療設施和高度集中的醫學研究機構。該地區人口老化程度高、慢性病發病率高，推動了對核成像設備和放射性同位素的需求。對醫療基礎設施的持續投資和領先醫科大學的存在進一步促進了關東地區核子影像市場的成長。

關西/近畿地區，包括大阪和京都等城市，是日本核子成像的重要市場。該地區以其強大的工業基礎和著名的醫療機構而聞名，對核成像服務的需求很高。人口老化以及癌症和心血管疾病等疾病的日益流行加劇了對先進診斷影像的需求。該地區對醫療保健創新的關注以及著名醫學研究中心的存在有助於擴大關西核成像市場。

包括名古屋在內的中部/中部地區在日本核子造影市場中發揮至關重要的作用。該地區強勁的製造業支持先進醫療設備的開發和銷售。老年人口的不斷成長和慢性病發病率的上升推動了對核成像的需求。該地區的主要醫療機構和研究機構強調早期疾病檢測和有效治療，進一步提振了市場。核子造影技術和醫療基礎設施發展的不斷進步是促進中部/中部地區市場成長的重要因素。

九州沖繩地區是日本核子成像的新興市場。該地區以其多樣化的人口和不斷成長的醫療保健需求而聞名，對先進診斷影像服務的需求不斷成長。慢性病的流行和人口老化需要加強醫療設施，包括核子造影。醫療保健基礎設施的投資和新醫學研究機構的建立正在推動市場成長。該地區致力於提高醫療保健的可及性和質量，有助於擴大九州-沖繩的核成像市場。

日本東北部的東北地區正在逐步開發其核子成像市場。該地區從 2011 年地震和海嘯中恢復過來，在醫療基礎設施方面進行了大量投資。人口老化和慢性病發病率的增加推動了對核成像等先進診斷工具的需求。當地醫療機構強調早期檢測和精確診斷，這刺激了對 SPECT 和 PET 影像的需求。不斷努力加強醫療服務和基礎設施是東北地區市場成長的關鍵。

位於本州西部的中國地區正在逐步擴大其核子成像市場。該地區的醫療保健需求是由人口老化和慢性病盛行率日益上升所推動的。對先進診斷影像技術（包括 SPECT 和 PET）的需求正在上升。對醫療保健基礎設施的投資以及重點醫科大學和研究中心的存在支持了市場成長。改善醫療服務和可近性的努力有助於中國地區核子影像市場的發展。

日本最北端的島嶼北海道地區的核子影像市場正在成長。該地區的醫療保健系統滿足人口老化和慢性病病例增加的需求。對核子造影服務（包括 SPECT 和 PET）的需求不斷增加，以實現精確的診斷和有效的治療計劃。對醫療保健基礎設施的投資，加上加強醫學研究和技術的舉措，正在推動市場發展。該地區致力於提高醫療品質和可近性，支持北海道核子成像市場的擴張。

日本最小的主要島嶼四國地區正在開發其核子成像市場。由於人口老化和慢性病盛行率上升，該地區面臨醫療保健挑戰。為了滿足這些需求，對 SPECT 和 PET 等先進診斷影像的需求不斷成長。對醫療保健設施的投資和改善醫療服務的努力正在促進市場成長。新醫學研究機構的建立和對早期疾病檢測的關注是推動四國地區核子影像市場擴張的關鍵因素。

日本核子造影市場最新動態：

  • 2024 年 4 月，博萊科集團在日本建立了直接業務，成立了博萊科日本公司，取代了合資企業博萊科衛材。義大利駐東京大使館慶祝這項舉措，恰逢義大利全國製造週。該公司旨在滿足日本市場對先進醫療產品和成像技術不斷成長的需求。博萊科日本公司將專注於開發新產品並加強與當地醫療界的關係。
  • 2024 年 4 月，GE HealthCare 在孟加拉為其 A1-Sure 超音波系統推出了一個新的翻新部門，旨在改善服務不足的二線和三線城市的醫療服務。該計劃包括高品質的翻新超音波設備，並提供檢查、保固和融資選項。此舉旨在為主要城市以外的地區提供負擔得起的醫療保健解決方案，為當地就業和能力建設創造機會。

本報告回答的關鍵問題：

  • 迄今為止，全球日本核子造影市場表現如何，未來幾年將如何表現？
  • 全球日本核子造影市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球日本核子造影市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了日本最具吸引力的核子成像市場？
  • 基於產品的市場區隔是什麼？
  • 日本核子造影市場最具吸引力的產品是什麼？
  • 基於應用的市場區隔是什麼？
  • 日本核子造影市場最有吸引力的應用是什麼？
  • 市場按地區分類是怎樣的？
  • 日本核子造影市場最有吸引力的地區是哪一個？
  • 市場競爭結構如何？
  • 全球日本核子造影市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 迄今為止，全球日本核子造影市場表現如何，未來幾年將如何表現？
  • 全球日本核子造影市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球日本核子造影市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了日本最具吸引力的核子成像市場？
  • 基於產品的市場區隔是什麼？
  • 日本核子造影市場最具吸引力的產品是什麼？
  • 基於應用的市場區隔是什麼？
  • 日本核子造影市場最有吸引力的應用是什麼？
  • 市場按地區分類是怎樣的？
  • 日本核子造影市場最有吸引力的地區是哪一個？
  • 市場競爭結構如何？
  • 全球日本核子造影市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：日本核子造影市場 - 簡介

  • 概述
  • 市場動態
  • 產業動態
  • 競爭情報

第 5 章：日本核子造影市場格局

  • 歷史與當前市場趨勢（2018-2023）
  • 市場預測（2024-2032）

第 6 章：日本核子造影市場 - 細分：依產品分類

  • 裝置
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）
  • 放射性同位素
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場區隔
      • SPECT放射性同位素
        • 锝-99m (TC-99m)
        • 鉈-201 (TI-201)
        • 鎵 (Ga-67)
        • 碘 (I-123)
        • 其他
      • PET放射性同位素
        • 氟18 (F-18)
        • 銣-82 (RB-82)
        • 其他
    • 市場預測（2024-2032）

第 7 章：日本核子造影市場 - 細分：按應用分類

  • 單光子發射斷層掃描應用
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場區隔
      • 骨科
      • 甲狀腺
      • 心臟病學
      • 其他
    • 市場預測（2024-2032）
  • 聚酯應用
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場區隔
      • 腫瘤學
      • 心臟病學
      • 神經病學
      • 其他
    • 市場預測（2024-2032）

第 8 章：日本核子造影市場 - 細分：按地區

  • 關東地區
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場區隔：按產品
    • 市場區隔：按應用
    • 關鍵參與者
    • 市場預測（2024-2032）
  • 關西/近畿地區
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場區隔：按產品
    • 市場區隔：按應用
    • 關鍵參與者
    • 市場預測（2024-2032）
  • 中部/中部地區
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場區隔：按產品
    • 市場區隔：按應用
    • 關鍵參與者
    • 市場預測（2024-2032）
  • 九州·沖繩地區
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場區隔：按產品
    • 市場區隔：按應用
    • 關鍵參與者
    • 市場預測（2024-2032）
  • 東北部地區
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場區隔：按產品
    • 市場區隔：按應用
    • 關鍵參與者
    • 市場預測（2024-2032）
  • 中國地區
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場區隔：按產品
    • 市場區隔：按應用
    • 關鍵參與者
    • 市場預測（2024-2032）
  • 北海道地區
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場區隔：按產品
    • 市場區隔：按應用
    • 關鍵參與者
    • 市場預測（2024-2032）
  • 四國地區
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場區隔：按產品
    • 市場區隔：按應用
    • 關鍵參與者
    • 市場預測（2024-2032）

第 9 章：日本核子造影市場 - 競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳制勝策略
  • 競爭儀表板
  • 公司評估象限

第 10 章：關鍵參與者簡介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

此處未提供公司名稱，因為這是目錄範例。最終報告中將提供完整的清單。

第 11 章：日本核子造影市場 - 產業分析

  • 促進因素、限制因素和機會
    • 概述
    • 促進要素
    • 限制
    • 機會
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅
  • 價值鏈分析

第 12 章：附錄

簡介目錄
Product Code: SR112024A16049

Japan nuclear imaging market is projected to exhibit a growth rate (CAGR) of 4.24% during 2024-2032. The market is experiencing significant growth mainly driven by technological advancements, growing geriatric population and increase in incidence of chronic disease. Government initiatives promoting early diagnosis, adoption of hybrid imaging technologies, significant investment in research and development (R&D) to enhance diagnostic precision and efficiency is driving the Japan nuclear imaging market growth.

Japan Nuclear Imaging Market Analysis:

  • Major Market Drivers: Key market drivers include the rising in prevalence of chronic disease, such as cancer and cardiovascular diseases, which necessitates advanced diagnostic imaging technologies. In line with this, the growing geriatric population further fuels the demand for advanced imaging technologies as older population are more prone to such conditions as compared to adults. Technological advancements in imaging equipment supported by substantial investment in research and development (R&D) further enhances the accuracy and efficiency of diagnostic procedures. Furthermore, the government initiatives and policies promoting early disease detection and improving healthcare infrastructure significantly boosts the Japan nuclear imaging market growth. The rising adoption of hybrid imaging techniques combining nuclear medicine with other imaging modalities also create a positive outlook for the market.
  • Key Market Trends: Key market trends include the growing adoption of hybrid imaging technologies such as PET/CT and SPECT/CT which offers enhanced diagnostic accuracy by combining functional and anatomical imaging. There is also significant shift towards the use of advanced radiopharmaceuticals which provide better imaging qualities and target specific diagnostics. The market is experiencing a significant rise in integration of artificial intelligence and machine learning to improve image analysis and streamline workflows. Furthermore, the focus on personalized medicine is driving the development of tailored nuclear imaging solutions which in turn is driving the Japan nuclear imaging market growth. Environmental sustainability is becoming a priority nowadays with efforts to reduce radiation exposure and improve efficiency of imaging systems.
  • Competitive Landscape: Key players in the market are heavily investing in research and development (R&D) to introduce innovative imaging technologies. Companies nowadays are also engaging in strategic partnerships and collaborations to expand their product portfolios and market reach. Furthermore, they are emphasizing environmental sustainability by creating more efficient, low radiation imaging solutions in order to meet regulatory standards and address healthcare needs.
  • Challenges and Opportunities: The market faces various challenges such as high costs associated with advanced imaging technologies and radiopharmaceuticals which can limit the accessibility and affordability. Regulatory hurdles and strict approval processes for new imaging agents and equipment also create significant barriers. However, these challenges create significant opportunities as well. The rising incidence of chronic disease and the growing geriatric population is driving the demand for precise diagnostic tools. Technological advancements including artificial intelligence and machine learning offers prospects for improved imaging accuracy and efficiency. Furthermore, government initiatives promoting early diagnosis and personalized medicine also present significant market growth avenues. Collaborations between industry players and in healthcare institutions are further enhancing the Japan nuclear imaging market growth and innovation.

Japan Nuclear Imaging Market Trends:

Rising Prevalence of Chronic Diseases

Rising prevalence of cancer in Japan necessitates advanced diagnostic tool which makes nuclear imaging important for early detection, accurate staging and monitoring treatment responses. According to a report published by National Library of Medicine, cancer has been the leading cause of death in Japan since 1981 accounting for 1/3 of total deaths. There were 1,019,000 new cancer cases and 380,400 cancer deaths in 2022. Techniques like PET/CT provide detailed images of cancerous tissues aiding in personalized treatment plans and improving patient outcomes. Similarly, cardiovascular disease a major health concern benefits significantly from nuclear imaging modalities such as SPECT and PET scans. These techniques help in assessing myocardial perfusion, detecting ischemia, and evaluating cardiac function, thereby facilitating timely and precise interventions. The growing reliance on nuclear imaging enhances the management of these chronic diseases, contributing to better health outcomes and prolonged patient survival.

Rising Geriatric Population

Japan's aging population significantly increases the demand for nuclear imaging services as older adults often require frequent diagnostic procedures for age-related health issues. According to an article published by BBC, national data shows that 29.1% of 125 million population in Japan is aged 65 or older. In Japan, people aged over 65 are expected to account for 34.8% of population by 2040. Conditions such as cancer, cardiovascular diseases and neurological disorders are more prevalent in elderly people which necessitates advanced imaging technologies for early detection and accurate diagnosis. Furthermore, age-related degenerative conditions such as Alzheimer disease benefits from nuclear imaging for early intervention. The rising geriatric demographic drives the Japan nuclear imaging market growth, ensuring better healthcare outcomes and quality of life for older adults.

Increase in Government Investments

Government investments in healthcare infrastructure in Japan are crucial in bolstering the nuclear imaging market. These investments include funding for state-of-the-art imaging technologies and facilities, ensuring that healthcare providers have access to the latest diagnostic tools. For instance, Japan Health 2025 aims to transform global healthcare with a focus on medical innovation and technology. The country's healthcare sector is evolving, with initiatives like the Japan Innovation Campus in Silicon Valley and advancements in Precision Medicine and regenerative medicine. Japan Health aspires to connect Japan with the world and elevate its healthcare industry to global standards. Such advancements improve diagnostic accuracy and patient care, driving the adoption of nuclear imaging. Furthermore, favorable regulatory policies support the market's growth by streamlining the approval process for new imaging technologies and radiopharmaceuticals. Government initiatives promoting research and development in nuclear imaging foster innovation and facilitate the introduction of cutting-edge techniques and treatments, ultimately enhancing the overall healthcare system and patient outcomes.

Japan Nuclear Imaging Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2024-2032. Our report has categorized the market based on product and application.

Breakup by Product:

  • Equipment
  • Radioisotope
    • SPECT Radioisotopes
  • Technetium-99m (TC-99m)
  • Thallium-201 (TI-201)
  • Gallium (Ga-67)
  • Iodine (I-123)
  • Others
    • PET Radioisotopes
  • Fluorine-18 (F-18)
  • Rubidium-82 (RB-82)
  • Others

The report has provided a detailed breakup and analysis of the market based on the product. This includes equipment and radioisotope [(SPECT radioisotopes (technetium-99m (tc-99m), thallium-201 (ti-201), gallium (ga-67), iodine (i-123), and others) and PET radioisotopes (fluorine-18 (f-18), rubidium-82 (rb-82), and others)].

The Japan nuclear imaging market for equipment is a vital component of the country's advanced healthcare infrastructure. Key equipment includes Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) scanners, which are essential for diagnosing various conditions, including cancer, cardiovascular diseases, and neurological disorders. The demand for such equipment is driven by Japan's aging population, increasing prevalence of chronic diseases, and advancements in imaging technologies. Moreover, the integration of artificial intelligence and machine learning in imaging equipment enhances diagnostic accuracy and efficiency, further propelling market growth. Continuous investments in healthcare infrastructure and rising awareness about early disease detection contribute significantly to the expansion of the nuclear imaging equipment market in Japan.

Radioisotopes are fundamental to Japan's nuclear imaging market, providing the necessary tracers for both SPECT and PET imaging techniques. SPECT radioisotopes, such as Technetium-99m (Tc-99m) and Thallium-201 (Tl-201), are extensively used for cardiac, bone, and tumor imaging due to their favorable properties and availability. PET radioisotopes, including Fluorine-18 (F-18) and Rubidium-82 (Rb-82), offer high-resolution imaging crucial for detecting cancer, neurological disorders, and cardiovascular diseases. The increasing prevalence of these conditions drives the demand for both SPECT and PET radioisotopes. Japan's robust healthcare infrastructure, coupled with its focus on advanced nuclear medicine research, supports the growing utilization of these radioisotopes, ensuring precise diagnostics and effective disease management.

Breakup by Application:

  • SPECT Applications
    • Orthopedics
    • Thyroid
    • Cardiology
    • Others
  • PET Applications
    • Oncology
    • Cardiology
    • Neurology
    • Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes SPECT applications (orthopedics, thyroid, cardiology, and others) and PET applications (oncology, cardiology, neurology, and others).

In Japan, SPECT applications are pivotal for diagnosing and monitoring various health conditions. Orthopedics benefits from SPECT imaging in detecting bone abnormalities and fractures. Thyroid imaging utilizes SPECT to assess thyroid function and detect disorders like hyperthyroidism or thyroid cancer. Cardiology applications use SPECT to evaluate myocardial perfusion and diagnose coronary artery disease. Other applications include brain imaging for epilepsy and dementia. The rising prevalence of these conditions, coupled with advancements in SPECT technology, drives the demand for SPECT applications in Japan's healthcare sector, ensuring precise diagnostics and improved patient outcomes.

PET applications are integral to Japan's nuclear imaging market, offering high-resolution imaging for various medical fields. Oncology heavily relies on PET for detecting and staging cancers, monitoring treatment response, and recurrence. Cardiology applications use PET to assess myocardial perfusion and viability, aiding in the diagnosis and management of heart diseases. Neurology benefits from PET imaging in diagnosing and evaluating neurological disorders like Alzheimer's disease and epilepsy. Other applications include infection and inflammation imaging. The increasing incidence of cancer, cardiovascular, and neurological diseases in Japan fuels the demand for PET applications, enhancing early detection and effective treatment strategies.

Breakup by Region:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

The Kanto Region, including Tokyo, is a significant market for nuclear imaging in Japan. As the most populous and economically developed region, it boasts advanced healthcare facilities and a high concentration of medical research institutions. The demand for nuclear imaging equipment and radioisotopes is driven by the region's large aging population and high incidence of chronic diseases. Continuous investments in healthcare infrastructure and the presence of leading medical universities further enhance the growth of the nuclear imaging market in the Kanto Region.

The Kansai/Kinki Region, encompassing cities like Osaka and Kyoto, is a crucial market for nuclear imaging in Japan. Known for its strong industrial base and prominent healthcare institutions, the region has a high demand for nuclear imaging services. The aging population and increasing prevalence of diseases such as cancer and cardiovascular disorders fuel the need for advanced diagnostic imaging. The region's focus on healthcare innovation and the presence of renowned medical research centers contribute to the expansion of the nuclear imaging market in Kansai.

The Central/Chubu Region, including Nagoya, plays a vital role in Japan's nuclear imaging market. This region's robust manufacturing industry supports the development and distribution of advanced medical equipment. The growing elderly population and the rising incidence of chronic illnesses drive the demand for nuclear imaging. Key healthcare institutions and research facilities in the region emphasize early disease detection and effective treatment, further boosting the market. Continuous advancements in nuclear imaging technology and healthcare infrastructure development are significant factors contributing to the market's growth in the Central/Chubu Region.

The Kyushu-Okinawa Region is an emerging market for nuclear imaging in Japan. Known for its diverse population and growing healthcare needs, the region sees increasing demand for advanced diagnostic imaging services. The prevalence of chronic diseases and the aging population necessitate enhanced healthcare facilities, including nuclear imaging. Investments in healthcare infrastructure and the establishment of new medical research institutions are driving market growth. The region's focus on improving healthcare accessibility and quality contributes to the expanding nuclear imaging market in Kyushu-Okinawa.

The Tohoku Region, in northeastern Japan, is progressively developing its nuclear imaging market. The region, recovering from the 2011 earthquake and tsunami, has seen significant investments in healthcare infrastructure. The aging population and increasing chronic disease rates drive the need for advanced diagnostic tools like nuclear imaging. Local healthcare institutions emphasize early detection and precise diagnostics, which fuel the demand for SPECT and PET imaging. Continuous efforts to enhance medical services and infrastructure are pivotal in the market growth in the Tohoku Region.

The Chugoku Region, located in western Honshu, is gradually expanding its nuclear imaging market. The region's healthcare needs are driven by its aging population and the increasing prevalence of chronic diseases. The demand for advanced diagnostic imaging technologies, including SPECT and PET, is rising. Investments in healthcare infrastructure and the presence of key medical universities and research centers support market growth. Efforts to improve healthcare services and accessibility contribute to the development of the nuclear imaging market in the Chugoku Region.

The Hokkaido Region, Japan's northernmost island, is witnessing growth in its nuclear imaging market. The region's healthcare system addresses the needs of an aging population and rising chronic disease cases. The demand for nuclear imaging services, including SPECT and PET, is increasing for precise diagnostics and effective treatment planning. Investments in healthcare infrastructure, coupled with initiatives to enhance medical research and technology, are driving the market. The region's focus on improving healthcare quality and accessibility supports the expansion of the nuclear imaging market in Hokkaido.

The Shikoku Region, Japan's smallest major island, is developing its nuclear imaging market. The region faces healthcare challenges due to its aging population and increasing chronic disease prevalence. The demand for advanced diagnostic imaging, such as SPECT and PET, is growing to meet these needs. Investments in healthcare facilities and efforts to improve medical services are contributing to market growth. The establishment of new medical research institutions and the focus on early disease detection are key factors driving the expansion of the nuclear imaging market in the Shikoku Region.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided.
  • The Japan Nuclear Imaging Market is highly competitive, characterized by the presence of various key players. These companies are leading the market through technological innovations, extensive research and development, and strategic collaborations. For instance, in April 2024, FUJIFILM Toyama Chemical and Synplogen entered a strategic business alliance on CDMO services for mRNA therapeutics. This alliance expands CDMO services to cover mRNA sequence design and plasmid DNA synthesis. Synplogen will provide mRNA sequence design and plasmid DNA synthesis services. By integrating expertise in mRNA sequence design and plasmid DNA synthesis, the companies aim to maximize customer value in the mRNA therapeutics industry and support its growth. Additionally, smaller domestic companies and startups are also contributing to market dynamism by introducing niche products and services. The market's competitiveness is further intensified by the increasing adoption of nuclear imaging for early diagnosis and treatment of chronic diseases.

Japan Nuclear Imaging Market Recent Developments:

  • In April 2024, Bracco Group establishes a direct presence in Japan with the launch of Bracco Japan, replacing the joint venture Bracco Eisai. The move is celebrated at the Italian Embassy in Tokyo and coincides with the National Made in Italy Week. The company aims to meet the growing demands for advanced medical products and imaging technologies in the Japanese market. Bracco Japan will focus on developing new products and strengthening relationships with the local medical community.
  • In April 2024, GE HealthCare launched a new refurbishing unit in Bangladesh for its A1-Sure Ultrasound Systems, aiming to improve healthcare access in underserved Tier 2 and Tier 3 cities. The initiative includes high-quality refurbished ultrasound equipment complete with inspections, warranty, and financing options. This move seeks to offer affordable healthcare solutions beyond major cities, creating opportunities for local employment and capacity building.

Key Questions Answered in This Report:

  • How has the global Japan nuclear imaging market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global Japan nuclear imaging market?
  • What is the impact of each driver, restraint, and opportunity on the global Japan nuclear imaging market?
  • What are the key regional markets?
  • Which countries represent the most attractive Japan nuclear imaging market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the Japan nuclear imaging market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the Japan nuclear imaging market?
  • What is the breakup of the market based on the region?
  • Which is the most attractive region in the Japan nuclear imaging market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global Japan nuclear imaging market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Nuclear Imaging Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Nuclear Imaging Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Nuclear Imaging Market - Breakup by Product

  • 6.1 Equipment
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Forecast (2024-2032)
  • 6.2 Radioisotope
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 SPECT Radioisotopes
        • 6.2.3.1.1 Technetium-99m (TC-99m)
        • 6.2.3.1.2 Thallium-201 (TI-201)
        • 6.2.3.1.3 Gallium (Ga-67)
        • 6.2.3.1.4 Iodine (I-123)
        • 6.2.3.1.5 Others
      • 6.2.3.2 PET Radioisotopes
        • 6.2.3.2.1 Fluorine-18 (F-18)
        • 6.2.3.2.2 Rubidium-82 (RB-82)
        • 6.2.3.2.3 Others
    • 6.2.4 Market Forecast (2024-2032)

7 Japan Nuclear Imaging Market - Breakup by Application

  • 7.1 SPECT Applications
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Segmentation
      • 7.1.3.1 Orthopedics
      • 7.1.3.2 Thyroid
      • 7.1.3.3 Cardiology
      • 7.1.3.4 Others
    • 7.1.4 Market Forecast (2024-2032)
  • 7.2 PET Applications
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Oncology
      • 7.2.3.2 Cardiology
      • 7.2.3.3 Neurology
      • 7.2.3.4 Others
    • 7.2.4 Market Forecast (2024-2032)

8 Japan Nuclear Imaging Market - Breakup by Region

  • 8.1 Kanto Region
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Breakup by Product
    • 8.1.4 Market Breakup by Application
    • 8.1.5 Key Players
    • 8.1.6 Market Forecast (2024-2032)
  • 8.2 Kansai/Kinki Region
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Breakup by Product
    • 8.2.4 Market Breakup by Application
    • 8.2.5 Key Players
    • 8.2.6 Market Forecast (2024-2032)
  • 8.3 Central/ Chubu Region
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Breakup by Product
    • 8.3.4 Market Breakup by Application
    • 8.3.5 Key Players
    • 8.3.6 Market Forecast (2024-2032)
  • 8.4 Kyushu-Okinawa Region
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2018-2023)
    • 8.4.3 Market Breakup by Product
    • 8.4.4 Market Breakup by Application
    • 8.4.5 Key Players
    • 8.4.6 Market Forecast (2024-2032)
  • 8.5 Tohoku Region
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2018-2023)
    • 8.5.3 Market Breakup by Product
    • 8.5.4 Market Breakup by Application
    • 8.5.5 Key Players
    • 8.5.6 Market Forecast (2024-2032)
  • 8.6 Chugoku Region
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2018-2023)
    • 8.6.3 Market Breakup by Product
    • 8.6.4 Market Breakup by Application
    • 8.6.5 Key Players
    • 8.6.6 Market Forecast (2024-2032)
  • 8.7 Hokkaido Region
    • 8.7.1 Overview
    • 8.7.2 Historical and Current Market Trends (2018-2023)
    • 8.7.3 Market Breakup by Product
    • 8.7.4 Market Breakup by Application
    • 8.7.5 Key Players
    • 8.7.6 Market Forecast (2024-2032)
  • 8.8 Shikoku Region
    • 8.8.1 Overview
    • 8.8.2 Historical and Current Market Trends (2018-2023)
    • 8.8.3 Market Breakup by Product
    • 8.8.4 Market Breakup by Application
    • 8.8.5 Key Players
    • 8.8.6 Market Forecast (2024-2032)

9 Japan Nuclear Imaging Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report.

11 Japan Nuclear Imaging Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix